Sagar A. Vaidya
Fate Therapeutics (United States)(US)
Publications by Year
Research Areas
Immune Response and Inflammation, Folate and B Vitamins Research, Metabolism and Genetic Disorders, interferon and immune responses, CRISPR and Genetic Engineering
Most-Cited Works
- → IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program(2002)834 cited
- Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.(2008)
- → Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection(2004)486 cited
- → Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism(2003)484 cited
- → Toll-like Receptors Induce a Phagocytic Gene Program through p38(2003)427 cited
- → Toll-Like Receptor 3 Mediates a More Potent Antiviral Response Than Toll-Like Receptor 4(2003)177 cited
- → Immune Activation of Type I IFNs by Listeria monocytogenes Occurs Independently of TLR4, TLR2, and Receptor Interacting Protein 2 but Involves TANK-Binding Kinase 1(2005)87 cited
- → First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B(2022)74 cited
- → Toll-like receptors and innate antiviral responses(2003)69 cited
- → Pelvic Abscess Due to Ochrobactrum anthropi in an Immunocompetent Host: Case Report and Review of the Literature(2006)58 cited